Kessler Topaz Meltzer & Check, LLP Encourages Maravai LifeSciences Holdings, Inc. Investors with Losses to Contact the FirmSearch for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Kessler Topaz Meltzer & Check, LLP Encourages Maravai LifeSciences Holdings, Inc. Investors with Losses to Contact the FirmRADNOR, PA - March 18, 2025 (NEWMEDIAWIRE) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Maravai LifeSciences Holdings, Inc. (“Maravai”) (
NASDAQMRVI) on behalf of those who purchased or otherwise acquired Maravai securities between August 7, 2024, and February 24, 2025, inclusive (the “Class Period”). The lead plaintiff deadline is May 5, 2025.
Kaplan Fox Alerts Maravai LifeSciences Holdings, Inc. (MRVI) Investors to a Securities Class Action Lawsuit - Deadline is May 5, 2025Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Kaplan Fox Alerts Maravai LifeSciences Holdings, Inc. (MRVI) Investors to a Securities Class Action Lawsuit - Deadline is May 5, 2025NEW YORK - March 17, 2025 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Maravai LifeSciences Holdings, Inc. (“Maravai” or the “Company”) (
NASDAQMRVI) on behalf of investors that purchased or otherwise acquired Maravai securities between August 7, 2024 and February 24, 2025 (the “Class Period”).
Maravai LifeSciences Holdings, Inc. (MRVI) Investors: May 5, 2025 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLPRADNOR, PA - March 16, 2025 (NEWMEDIAWIRE) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Maravai LifeSciences Holdings, Inc. (“Maravai”) (
NASDAQMRVI) on behalf of those who purchased or otherwise acquired Maravai securities between August 7, 2024, and February 24, 2025, inclusive (the “Class Period”). The lead plaintiff deadline is May 5, 2025.
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Maravai LifeSciencesFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Maravai LifeSciences To Contact Him Directly To Discuss Their Options
MARAVAI LIFESCIENCES DEADLINE: Investors Are Encouraged to Contact Kaplan Fox Before the Lead Plaintiff Deadline on May 5, 2025Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
MARAVAI LIFESCIENCES DEADLINE: Investors Are Encouraged to Contact Kaplan Fox Before the Lead Plaintiff Deadline on May 5, 2025NEW YORK - March 15, 2025 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Maravai LifeSciences Holdings, Inc. (“Maravai” or the “Company”) (
NASDAQMRVI) on behalf of investors that purchased or otherwise acquired Maravai securities between August 7, 2024 and February 24, 2025 (the “Class Period”).
Maravai LifeSciences Holdings, Inc. (MRVI) Investors: May 5, 2025 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLPRADNOR, PA - March 14, 2025 (NEWMEDIAWIRE) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Maravai LifeSciences Holdings, Inc. (“Maravai”) (
NASDAQMRVI) on behalf of those who purchased or otherwise acquired Maravai securities between August 7, 2024, and February 24, 2025, inclusive (the “Class Period”). The lead plaintiff deadline is May 5, 2025.
MARAVAI LIFESCIENCES Deadline to Lead in Securities Fraud Lawsuit is May 5, 2025 Contact Kaplan Fox & Kilsheimer LLPSearch for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
MARAVAI LIFESCIENCES Deadline to Lead in Securities Fraud Lawsuit is May 5, 2025 Contact Kaplan Fox & Kilsheimer LLPNEW YORK - March 14, 2025 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Maravai LifeSciences Holdings, Inc. (“Maravai” or the “Company”) (
NASDAQMRVI) on behalf of investors that purchased or otherwise acquired Maravai securities between August 7, 2024 and February 24, 2025 (the “Class Period”).
Deadline to Lead in Securities Fraud Lawsuit Against Maravai LifeSciences Holdings, Inc. (MRVI) is May 5, 2025 Contact Kaplan Fox & Kilsheimer LLPNEW YORK - March 13, 2025 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Maravai LifeSciences Holdings, Inc. (“Maravai” or the “Company”) (
NASDAQMRVI) on behalf of investors that purchased or otherwise acquired Maravai securities between August 7, 2024 and February 24, 2025 (the “Class Period”).
Marvai LifeSciences Holdings, Inc. Shareholders with Large Losses are Encouraged to Contact Robbins LLP for Information About Leading the Securities Fraud Class Action Lawsuit Against MRVISAN DIEGO, March 12, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of persons and entities that purchased or otherwise acquired Maravai LifeSciences Holdings, Inc. (
NASDAQMRVI) securities between August 7, 2024 and February 24, 2025. Maravai is a life sciences company that provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases worldwide.
Kaplan Fox & Kilsheimer LLP Alerts Investors to a Securities Class Action Against Maravai LifeSciences Holdings, Inc. (MRVI) - Deadline is May 5, 2025NEW YORK - March 12, 2025 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Maravai LifeSciences Holdings, Inc. (“Maravai” or the “Company”) (
NASDAQMRVI) on behalf of investors that purchased or otherwise acquired Maravai securities between August 7, 2024 and February 24, 2025 (the “Class Period”).
MRVI INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Maravai LifeSciences Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Maravai LifeSciences Holdings, Inc. (
NASDAQMRVI) securities between August 7, 2024 and February 24, 2025, both dates inclusive (the “Class Period”), have until May 5, 2025 to seek appointment as lead plaintiff of the Maravai class action lawsuit. Captioned Nelson v. Maravai LifeSciences Holdings, Inc., No. 25-cv-00499 (S.D. Cal.), the Maravai class action lawsuit charges Maravai as well as certain of Maravai’s top executives with violations of the Securities Exchange Act of 1934.
Lowey Dannenberg Notifies Maravai LifeSciences Holdings, Inc. (“Maravai” or the “Company”) (NASDAQ: MRVI) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $50,000 in Losses to Contact the FirmNEW YORK, March 12, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Maravai LifeSciences Holdings, Inc. (“Maravai” or the “Company”) (
NASDAQMRVI) for violations of the federal securities laws on behalf of investors who purchased or acquired Maravai common stock between August 7, 2024 and February 24, 2025, inclusive (the “Class Period”).
MRVI REMINDER: Kessler Topaz Meltzer & Check, LLP Urges MRVI Investors With Losses to Contact the FirmSearch for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
MRVI REMINDER: Kessler Topaz Meltzer & Check, LLP Urges MRVI Investors With Losses to Contact the FirmRADNOR, PA - March 12, 2025 (NEWMEDIAWIRE) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Maravai LifeSciences Holdings, Inc. (“Maravai”) (
NASDAQMRVI) on behalf of those who purchased or otherwise acquired Maravai securities between August 7, 2024, and February 24, 2025, inclusive (the “Class Period”). The lead plaintiff deadline is May 5, 2025.
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Maravai LifeSciencesFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Maravai LifeSciences To Contact Him Directly To Discuss Their Options
